Relationships between heritable dementia risk factors, cardiovascular risk factors in young adulthood, and midlife neuropsychological outcomes
Open Access
- 6 January 2026
- journal article
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 109 (2) , 757-767
Abstract
Background: Selected cardiovascular factors, APOE4 carriership, and family history (FH) are robust risk factors for Alzheimer's disease and dementia. While cardiovascular risk tends to affect cognition from midlife, it remains unclear whether heritable risk predicts cardiovascular health in young adulthood and midlife, and whether young-adult cardiovascular health predicts midlife cognition. Objective: We sought to examine how heritable dementia risk relates to cardiovascular health and how these cardiovascular risk factors in young adulthood predict midlife brain volumes and cognition. Methods: We used data from the CARDIA study, which followed 5115 individuals aged 18–30 at baseline over 30 years. Analyses focused on 2808 participants (Mean age = 60, SD = 3.58) who attended the 30-year visit. We examined associations between APOE4 and FH with baseline and 30-year follow-up measures of cardiovascular risk factors (LDL-C, HDL-C, glucose, blood pressure, body mass index (BMI), smoking), cognition, and brain volumes. Results: APOE4 carriers with FH had higher LDL-C and lower HDL-C levels as early as young adulthood, persisting into midlife. BMI and smoking were the only cardiovascular risk factors from young adulthood that predicted midlife cognition. There was no association between young adult cardiovascular risk factors and midlife brain volumes, but those with heritable dementia risk had larger brain volumes in regions vulnerable to midlife atrophy. Conclusions: APOE4 carriership was associated with an unfavorable lipid profile that started in early adulthood and persisted to later life. Early cardiovascular risk was also associated with midlife cognition, which is earlier than studies typically focusing on later-life cognition.Keywords
Funding Information
- National Heart, Lung, and Blood Institute (HHSN268201800003I)
- National Heart, Lung, and Blood Institute (HHSN268201800004I)
- National Heart, Lung, and Blood Institute (HHSN268201800005I)
- National Heart, Lung, and Blood Institute (HHSN268201800006I)
- National Heart, Lung, and Blood Institute (HHSN268201800007I)
- Intramural Research Program (AG0005)
This publication has 54 references indexed in Scilit:
- APOE genotype, cholesterol level, lipid-lowering treatment, and dementiaNeurology, 2005
- The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive ImpairmentJournal of the American Geriatrics Society, 2005
- Aging and insulin secretionAmerican Journal of Physiology-Endocrinology and Metabolism, 2003
- Insulin Resistance with AgingSports Medicine, 2000
- Hemodynamic Patterns of Age-Related Changes in Blood PressureCirculation, 1997
- Apolipoprotein E in Alzheimer's disease risk and case detection: A case-control studyJournal of Clinical Epidemiology, 1996
- Simplified isoelectric focusing/immunoblotting determination of apoprotein E phenotypeClinical Chemistry, 1994
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993
- Familial Aggregation of Alzheimer's Disease and Related Disorders: A Collaborative Re-Analysis of Case-Control StudiesInternational Journal of Epidemiology, 1991
- Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative UltracentrifugeClinical Chemistry, 1972